WebDec 5, 2024 · Interpace Pharma Solutions is a market leader in providing pharmacogenomics testing, genotyping, and biorepository services to the pharmaceutical and biotech industries. WebAcquisition significantly expands Flagship’s portfolio of biomarker and analytics services BROOMFIELD, Colo., August 31, 2024—Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the acquisition of Interpace Pharma Solutions® (“IPS”), a division of Interpace Biosciences and provider of cytogenetic, …
Interpace Pharma Solutions
WebMar 17, 2024 · Employees. 152. Revenue. 41M USD (2024) DESCRIPTION. Interpace engages in enabling personalized medicine, offering specialized services along the … WebInterpace Pharma Solutions (IPS) provides expert-based collaborative solutions and high quality services in support of their clients’ therapeutic development programs. By … solicitors in wembley park
Flagship Acquires Interpace’s Pharma Services Business
WebSearch Interpace Diagnostics Group, Inc. Lease Agreements business contracts filed with the Securities ... 201 Route 17 North, Rutherford, New Jersey, effective March 31,... WebAug 31, 2024 · Interpace Transitions to focused Molecular Diagnostics BusinessDisposition of Pharma Services Expected to Improve Operating Cash Flow by nearly $5 million … WebParsippany, NJ, April 12, 2024 (GLOBE NEWSWIRE) -- Interpace Pharma Solutions, a subsidiary of Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) announced today new capability in advancing RNA biomarker analysis for gene and cell-based therapies. RNAscope ® in situ hybridization (ISH) is a new Interpace offering ... smaland marine traffic